All

Each year during the membership renewal period, members graciously donate monies so that fellow oncology pharmacy practitioners, who might otherwise not be able to join ISOPP, are afforded the opportunity.

 

By Jennifer Jupp, ISOPP Research Committee Chair

 

Finally! For the first time in three years, ISOPP members were able to connect in our first in-person Symposium. ISOPP’s XXI International Symposium on Oncology Pharmacy Practice (ISOPP 2023) took place March 2-4, 2023 in the beautiful, historical city of Seville, Spain.

"We enjoyed the city of Seville, valued the networking opportunities, and appreciated the glimpse into the vibrant culture..."

 

ISOPP Members, the one hundred and fourth issue of the Virtual Journal Club (VJC) is available on the International Society of Oncology Pharmacy Practitioners (ISOPP) website. To access it, visit the https://www.isopp.org/isopp-education-resources/virtual-journal-club-surveys 

 

ISOPP’s 2023 Secretariat election took place in January/February. Thank you all for your participation and welcome aboard to our newly elected Secretariat members.

 

Discover the Program! Hotel room rates further reduced!

It’s just over one month to the ISOPP 2023 Symposium and Masterclasses! Join us for leading edge education to advance your oncology pharmacy knowledge in scenic Seville! 

Register Now and leave ISOPP 2023 with key insights and strategies!

 

ISOPP Members, the ISOPP quarterly Newsletter was distributed to your inbox on Friday, January 20th. Read about updates and other important news from ISOPP!

 

ISOPP Members, the one hundred and third issue of the Virtual Journal Club (VJC) is available on the International Society of Oncology Pharmacy Practitioners (ISOPP) website. To access it, visit the https://www.isopp.org/isopp-education-resources/virtual-journal-club-surveys 

 

The ISOPP 2023 Symposium and Masterclasses are less than 6 weeks away! Join us for leading edge education to advance your oncology pharmacy knowledge in scenic Seville! 

 

With a new year ahead, the Advocacy Committee is in close collaboration with international organizations such as the World Health Organization (WHO). The Cancer Manual includes resources adapted treatment regimens for low- and middle-income countries and is also linked to the WHO Essential Medicines List (EML). It will be developed in collaboration with WHO in the following months of this year.